KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Change in Accured Expenses (2016 - 2025)

Historic Change in Accured Expenses for Medpace Holdings (MEDP) over the last 11 years, with Q3 2025 value amounting to $45.3 million.

  • Medpace Holdings' Change in Accured Expenses rose 24776.46% to $45.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $60.5 million, marking a year-over-year increase of 4716.48%. This contributed to the annual value of $16.9 million for FY2024, which is 7943.23% down from last year.
  • Latest data reveals that Medpace Holdings reported Change in Accured Expenses of $45.3 million as of Q3 2025, which was up 24776.46% from $35.4 million recorded in Q2 2025.
  • Over the past 5 years, Medpace Holdings' Change in Accured Expenses peaked at $45.3 million during Q3 2025, and registered a low of -$23.2 million during Q1 2025.
  • Moreover, its 5-year median value for Change in Accured Expenses was $13.0 million (2024), whereas its average is $12.4 million.
  • Over the last 5 years, Medpace Holdings' Change in Accured Expenses had its largest YoY gain of 62634.1% in 2021, and its largest YoY loss of 47159.93% in 2021.
  • Medpace Holdings' Change in Accured Expenses (Quarter) stood at $1.5 million in 2021, then skyrocketed by 215.9% to $4.6 million in 2022, then skyrocketed by 486.8% to $27.2 million in 2023, then crashed by 89.14% to $2.9 million in 2024, then surged by 1435.16% to $45.3 million in 2025.
  • Its last three reported values are $45.3 million in Q3 2025, $35.4 million for Q2 2025, and -$23.2 million during Q1 2025.